company background image
4169 logo

TCM Biotech International TPEX:4169 Stock Report

Last Price

NT$56.10

Market Cap

NT$3.3b

7D

0%

1Y

-13.0%

Updated

19 Jul, 2024

Data

Company Financials +

TCM Biotech International Corp.

TPEX:4169 Stock Report

Market Cap: NT$3.3b

4169 Stock Overview

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.

4169 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends0/6

TCM Biotech International Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for TCM Biotech International
Historical stock prices
Current Share PriceNT$56.10
52 Week HighNT$68.30
52 Week LowNT$49.75
Beta0.043
11 Month Change0.90%
3 Month Change10.87%
1 Year Change-13.02%
33 Year Change111.78%
5 Year Change149.96%
Change since IPO95.66%

Recent News & Updates

Recent updates

Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?

Jan 31
Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?

Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend

Jan 04
Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend

We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt

Dec 07
We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt

Shareholder Returns

4169TW BiotechsTW Market
7D0%4.5%-3.8%
1Y-13.0%9.3%34.7%

Return vs Industry: 4169 underperformed the TW Biotechs industry which returned 9.3% over the past year.

Return vs Market: 4169 underperformed the TW Market which returned 34.7% over the past year.

Price Volatility

Is 4169's price volatile compared to industry and market?
4169 volatility
4169 Average Weekly Movement3.5%
Biotechs Industry Average Movement5.7%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4169 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4169's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998n/aYa-Chun Wangwww.tcmbio.com

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company’s products include osteoarthritis treatment products, osteoporosis treatment preparations, iron supplement, urinary system treatment products, expectorants/mucolytic agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.

TCM Biotech International Corp. Fundamentals Summary

How do TCM Biotech International's earnings and revenue compare to its market cap?
4169 fundamental statistics
Market capNT$3.31b
Earnings (TTM)NT$18.57m
Revenue (TTM)NT$969.62m

178.3x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4169 income statement (TTM)
RevenueNT$969.62m
Cost of RevenueNT$489.45m
Gross ProfitNT$480.17m
Other ExpensesNT$461.59m
EarningsNT$18.57m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.31
Gross Margin49.52%
Net Profit Margin1.92%
Debt/Equity Ratio10.3%

How did 4169 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

81%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.